Rainbow Childrens Medicare Limited has informed the Exchange regarding Appointment of Dr. Ramesh Kancharla as Chairman & Managing Director of the company w.e.f. August 11, 2026.
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare Limited's Board meeting on May 23, 2026 approved the audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with an unmodified opinion from Statutory Auditors S.R. Batliboi & Associates LLP. The Board recommended a final dividend of ₹3.5 per equity share (35% on face value of ₹10) for FY 2025-26, payable after shareholder approval at the 28th AGM scheduled for July 29, 2026. Key appointments include re-appointment of Dr. Ramesh Kancharla (founding promoter) as Chairman and Managing Director for 5 years from August 2026, Dr. Dinesh Kumar Chirla (promoter) as Whole Time Director for 5 years, and re-appointment of two Independent Directors (Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati) for second terms of 5 years each. Cost Auditors M/s. Lavanya & Associates LLP were also re-appointed for FY 2026-27.
The re-appointment of the founding promoter as Chairman and Managing Director provides continuity in leadership. The dividend recommendation and AGM scheduling are routine governance matters. The audited financials with clean audit opinion indicate financial health.